the early ebi group had a longer brain metastasis-free survival than the late ebi group , even among patients with bone metastasis ( p = 0.02 ) or bone marrow metastasis ( p = 0.05 ) and those who achieved complete remission after induction chemotherapy ( p = 0.06 ) or as a best response ( p = 0.05 ) .
C0006104
ebi
C0220650
brain metastasis